XML 12 R2.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 49,476 $ 29,754
Marketable securities, current 220,849 246,399
Accounts receivable 528 1,473
Prepaid expenses and other current assets 7,599 9,931
Total current assets 278,452 287,557
Marketable securities, non-current 34,706 60,962
Property and equipment, net 7,640 7,400
Right-of-use asset 68,599 70,116
Restricted cash 3,279 3,279
Other assets 3,360 1,526
Total assets 396,036 430,840
Current liabilities:    
Accounts payable 1,034 1,172
Accrued expenses and other current liabilities 16,295 19,769
Deferred revenue, current 14,937 16,618
Operating lease liability, current 4,827 4,700
Long-term debt − related party, current and net of discount 2,287 2,287
Total current liabilities 39,380 44,546
Deferred revenue, net of current 15,845 16,895
Operating lease liability, net of current 69,720 70,970
Long-term debt − related party, net of current and discount 8,621 9,195
Total liabilities 133,566 141,606
Commitments and contingencies (see Note 11)
Stockholders’ equity:    
Preferred stock, par value of $0.0001 per share; 10,000,000 shares authorized, and no shares issued or outstanding as of March 31, 2023 and December 31, 2022, respectively 0 0
Common stock, par value of $0.0001 per share; 150,000,000 shares authorized, and 49,052,509 and 48,966,216 shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively 5 5
Additional paid-in capital 695,605 689,256
Accumulated other comprehensive loss (2,470) (4,137)
Accumulated deficit (430,670) (395,890)
Total stockholders’ equity 262,470 289,234
Total liabilities and stockholders’ equity $ 396,036 $ 430,840